Biomedical Engineering Reference
In-Depth Information
[12] Tassa C, Shaw SY, Weissleder R. Dextran-coated iron oxide nanoparticles: a versatile
platform for targeted molecular imaging, molecular diagnostics, and therapy. acc Chem
Res 2011;
44
:842-852.
[13] Tu C, louie aY. Nanoformulations for molecular MRI. Wiley Interdiscip Rev Nanomed
Nanobiotechnol 2012;
4
:448-457.
[14] Hu f, Joshi HM, Dravid VP, Meade TJ. High-performance nanostructured MR contrast
probes. Nanoscale 2010;
2
:1884-1891.
[15] lanza gM, Winter PM, Caruthers SD, Hughes MS, Hu g, Schmieder aH, Wickline Sa.
Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions.
angiogenesis 2010;
13
:189-202.
[16] Caruthers SD, Cyrus T, Winter PM, Wickline Sa, lanza gM. anti-angiogenic perfluo-
rocarbon nanoparticles for diagnosis and treatment of atherosclerosis. Wiley Interdiscip
Rev Nanomed Nanobiotechnol 2009;
1
:311-323.
[17] Stanisz gJ, Henkelman RM. gd-DTPa relaxivity depends on macromolecular content.
Magn Reson Med 2000;
44
:665-667.
[18] Morawski aM, Winter PM, Crowder KC, Caruthers SD, fuhrhop RW, Scott MJ,
Robertson JD, abendschein DR, lanza gM, Wickline Sa. Targeted nanoparticles for
quantitative imaging of sparse molecular epitopes with MRI. Magn Reson Med 2004;
51
:480-486.
[19] Mulder WJ, Castermans K, van Beijnum JR, oude Egbrink Mg, Chin PT, fayad Za,
lowik CW, Kaijzel El, Que I, Storm g, Strijkers gJ, griffioen aW, Nicolay K. Molecular
imaging of tumor angiogenesis using alphavbeta3-integrin targeted multimodal quantum
dots. angiogenesis 2009;
12
:17-24.
[20] Zhu W, okollie B, Bhujwalla ZM, artemov D. PaMaM dendrimer-based contrast agents
for MR imaging of Her-2/neu receptors by a three-step pretargeting approach. Magn
Reson Med 2008;
59
:679-685.
[21] Maiseyeu a, Mihai g, Kampfrath T, Simonetti oP, Sen CK, Roy S, Rajagopalan S,
Parthasarathy S. gadolinium-containing phosphatidylserine liposomes for molecular
imaging of atherosclerosis. J lipid Res 2009;
50
:2157-2163.
[22] Paulis lE, Jacobs I, van den akker NM, geelen T, Molin Dg, Starmans lW, Nicolay K,
Strijkers gJ. Targeting of ICaM-1 on vascular endothelium under static and shear stress
conditions using a liposomal gd-based MRI contrast agent. J Nanobiotechnol 2012;
10
:25.
[23] Hartmann M, Wiethoff aJ, Hentrich HR, Rohrer M. Initial imaging recommendations for
Vasovist angiography. Eur Radiol 2006;
16
(Suppl 2):B15-B23.
[24] overoye-Chan K, Koerner S, looby RJ, Kolodziej af, Zech Sg, Deng Q, Chasse JM,
McMurry TJ, Caravan P. EP-2104R: a fibrin-specific gadolinium-Based MRI contrast
agent for detection of thrombus. J am Chem Soc 2008;
130
:6025-6039.
[25] Spuentrup E, Botnar RM, Wiethoff aJ, Ibrahim T, Kelle S, Katoh M, ozgun M, Nagel E,
Vymazal J, graham PB, gunther RW, Maintz D. MR imaging of thrombi using
EP-2104R, a fibrin-specific contrast agent: initial results in patients. Eur Radiol 2008;
18
:
1995-2005.
[26] Vymazal J, Spuentrup E, Cardenas-Molina g, Wiethoff aJ, Hartmann Mg, Caravan P,
Parsons EC Jr. Thrombus imaging with fibrin-specific gadolinium-based MR contrast
agent EP-2104R: results of a phase II clinical study of feasibility. Invest Radiol 2009;
44
:
697-704.
[27] Rieke V, Butts Pauly K. MR thermometry. J Magn Reson Imaging 2008;
27
:376-390.
Search WWH ::
Custom Search